About Rafik Hariri University Hospital
The Rafik Hariri University Hospital – formerly known as Beirut Governmental University Hospital – is the largest Lebanese public hospital, located on the outskirts of southern Beirut.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Rafik Hariri University Hospital
During the past decade, Rafik Hariri University Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 8 clinical trials were completed, i.e. on
average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Rafik Hariri University Hospital" #1 sponsor was "Rafic Hariri University Hospital" with 5 trials, followed by "Shire" with 3 trials
sponsored, "AB Science" with 2 trials sponsored, "American University of Beirut Medical Center" with 2 trials sponsored and "Boehringer Ingelheim"
with 2 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Rafik Hariri University Hospital"
#1 collaborator was "American University of Beirut Medical Center" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Ark Biosciences Pty Ltd." with 1 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator and "Hammoud Hospital" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Rafik Hariri University Hospital
According to Clinical.Site data, the most researched conditions in "Rafik Hariri University Hospital" are
"Crohn's Disease" (3 trials), "Sickle Cell Anemia" (3 trials), "Sickle Cell Disease" (3 trials), "Sickle Cell Disorders" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "Rafik Hariri University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Rafik Hariri University Hospital
Most popular intervention types in "Rafik Hariri University Hospital" are "Drug" (18 trials), "Other" (2 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Gemcitabine" (2 trials), "HQK-1001" (2 trials), "Masitinib" (2 trials) and "Ontamalimab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Rafik Hariri University Hospital
The vast majority of trials in "Rafik Hariri University Hospital" are
25 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Rafik Hariri University Hospital
Currently, there are NaN active trials in "Rafik Hariri University Hospital".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Rafik Hariri University Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Rafik Hariri University Hospital, 3 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".